A relatively new class of investment has emerged, formed especially to own renewable energy assets, that can offer growth and high income. Read More

The U.S. Department of Veterans Affairs has initiated comprehensive research on the application of psychedelics in treating PTSD. Read More

Estimated corporate profitability for Q4 and into 2024 could offset growing investor anxieties about interest rates and geopolitics. Read More

This week, I take a look back at the sector winners and losers of 2023. The clear winner last year was technology. Read More

Here's a re-cap of last week's action on Wall Street, with a look at the week ahead. Equities slumped last week, but bullish factors prevail. Read More

Here are the pros and cons of a second paycheck for a family with kids. The calculations might surprise you. Read More

This video looks at the ABBV trade, which is expiring January 5. We're making a 33% gain on this trade, over a period of 3 ½ months. Read More

Just when you thought the pandemic was behind us, respiratory illnesses such as the coronavirus and influenza are on the rise. Read More

Electronic health records are emerging as among the most prevalent targets for fraud and cyber theft. Take these protective measures now. Read More

From the state grassroots to Congress, here’s a review of key pending legislative developments in marijuana (and psychedelics) for 2024. Read More